Form 4: Kenvue CSO Caroline Tillett Reports Stock Transactions

Kenvue's Chief Scientific Officer, Caroline Tillett, reported the acquisition of common stock through RSU vesting and subsequent tax-related dispositions.

Summary

• Caroline Tillett, Chief Scientific Officer of Kenvue Inc. (KVUE), reported transactions on December 1, 2025.
• Acquired 1,538.75 shares of Kenvue Common Stock upon the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Disposed of 788 shares of Common Stock at $17.22 per share to cover tax obligations related to the RSU vesting.
• Following these transactions, Tillett beneficially owns 44,879.51 shares of Common Stock directly.
• Also holds 1,538.86 Restricted Stock Units directly, which correspond one-for-one with common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transactions are routine for RSU vesting and tax withholding, indicating continued executive compensation and ownership alignment, but no new strategic or financial news.

Positives

• Officer's continued ownership of a significant number of shares (44,879.51 Common Stock and 1,538.86 RSUs) aligns her interests with shareholders.
• The acquisition of shares through RSU vesting indicates the fulfillment of long-term incentive compensation.

Negatives

• Disposition of 788 shares, although for tax purposes, reduces direct ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Indicates continued alignment of executive interests with shareholders through equity ownership.
• Employees: Reflects standard executive compensation practices involving equity awards.

Next Steps

• Future RSU vesting on December 1, 2026, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to the vesting of Restricted Stock Units and subsequent tax withholding. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The Chief Scientific Officer's continued significant equity ownership aligns her interests with shareholders, which is generally a positive, but the transaction itself is not a discretionary purchase or sale based on new insights. Therefore, a 'hold' recommendation is appropriate as this filing does not present new catalysts for a 'buy' or 'sell' decision.

Keywords

Kenvue, KVUE, Caroline Tillett, Chief Scientific Officer, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Common Stock